Announcements Trials

Browse Landscape

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Prostatic Neoplasms 1 Adenocarcinoma 1

Interventions

Gemcitabine 3 Nivolumab 2 temoporfin 1 spartalizumab 1 polysaccharide-K 1 pembrolizumab 1 nimotuzumab 1 devimistat 1 dalotuzumab 1 bemarituzumab 1 belinostat 1 Transurethral Resection of Prostate 1 Radiotherapy, Intensity-Modulated 1 Radiotherapy 1 Radiofrequency Ablation 1 Oxaliplatin 1 Morphine 1 Methadone 1 Leucovorin 1 Ipilimumab 1 Interviews as Topic 1 Injections 1 Immunotherapy 1 Heavy Ion Radiotherapy 1 Fluorouracil 1 Erlotinib Hydrochloride 1 Docetaxel 1 Cryosurgery 1 Cisplatin 1 Brachytherapy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Withdrawn × Adenocarcinoma × Transurethral Resection of Prostate × Clear all

NCT07237399 2026-05-13

TA-P-OLIM

University Hospital, Ghent

Adenocarcinoma, Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡